 Planned Follow-up: If the patients physician believes the patient is responding well to treatment, the patient may receive up to 16 cycles of Brentuximab Vedotin. The Investigator would like to keep track of patients medical condition for 12 months after the patient has completed the first 2 cycles of treatment, no matter if the patient receives more doses or not. The Investigator would like to do this by calling the patient on the telephone to see how heshe is doing. Keeping in touch with patient and checking the condition helps the Investigator look at the long-term effects of the research study. 